AstraZeneca UK Limited

Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Patient Information Leaflet last updated on the eMC: 24/08/2011
PIL Oxis Turbohaler 6, inhalation powder

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 19/10/2010 and displayed until 24/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 01/12/2008 and displayed until 19/10/2010
Reasons for adding or updating:
  • Addition of separate PILs covering individual presentations
  • Change due to user-testing of patient information
Updated on 23/03/2007 and displayed until 01/12/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 09/02/2005 and displayed until 23/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 09/08/2004 and displayed until 09/02/2005
Reasons for adding or updating:
  • Change to date of revision
Updated on 01/04/2004 and displayed until 09/08/2004
Reasons for adding or updating:
  • Change to date of revision
Updated on 26/09/2002 and displayed until 01/04/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 01/11/2000 and displayed until 26/09/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   formoterol fumarate dihydrate